These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11704386)

  • 1. Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up.
    Wyse DG; Friedman PL; Brodsky MA; Beckman KJ; Carlson MD; Curtis AB; Hallstrom AP; Raitt MH; Wilkoff BL; Greene HL;
    J Am Coll Cardiol; 2001 Nov; 38(6):1718-24. PubMed ID: 11704386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators.
    Steinberg JS; Beckman K; Greene HL; Marinchak R; Klein RC; Greer SG; Ehlert F; Foster P; Menchavez E; Raitt M; Wathen MS; Morris M; Hallstrom A
    J Cardiovasc Electrophysiol; 2001 Sep; 12(9):996-1001. PubMed ID: 11573709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Raitt MH; Klein RC; Wyse DG; Wilkoff BL; Beckman K; Epstein AE; Coromilas J; Friedman PL; Martins J; Ledingham RB; Greene HL;
    Am J Cardiol; 2003 Apr; 91(7):812-6. PubMed ID: 12667566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyssynchrony and the risk of ventricular arrhythmias.
    Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.
    Exner DV; Pinski SL; Wyse DG; Renfroe EG; Follmann D; Gold M; Beckman KJ; Coromilas J; Lancaster S; Hallstrom AP;
    Circulation; 2001 Apr; 103(16):2066-71. PubMed ID: 11319196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial.
    Mitchell LB; Powell JL; Gillis AM; Kehl V; Hallstrom AP;
    J Am Coll Cardiol; 2003 Jul; 42(1):81-7. PubMed ID: 12849664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ;
    J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Exner DV; Reiffel JA; Epstein AE; Ledingham R; Reiter MJ; Yao Q; Duff HJ; Follmann D; Schron E; Greene HL; Carlson MD; Brodsky MA; Akiyama T; Baessler C; Anderson JL
    J Am Coll Cardiol; 1999 Aug; 34(2):325-33. PubMed ID: 10440140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry.
    Ehlert FA; Cannom DS; Renfroe EG; Greene HL; Ledingham R; Mitchell LB; Anderson JL; Halperin BD; Herre JM; Luceri RM; Marinchak RA; Steinberg JS
    Am Heart J; 2001 Nov; 142(5):816-22. PubMed ID: 11685168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators.
    Anderson JL; Hallstrom AP; Epstein AE; Pinski SL; Rosenberg Y; Nora MO; Chilson D; Cannom DS; Moore R
    Circulation; 1999 Apr; 99(13):1692-9. PubMed ID: 10190878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.
    Tsai CT; Huang SK; Lin JL; Lai LP;
    Pacing Clin Electrophysiol; 2003 Nov; 26(11):2083-90. PubMed ID: 14622308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Biering-Sørensen T; Knappe D; Pouleur AC; Claggett B; Wang PJ; Moss AJ; Solomon SD; Kutyifa V
    Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28003221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of device detected atrial and ventricular tachyarrhythmia with adverse events in patients with an implantable cardioverter-defibrillator.
    Abbas H; Younis A; Goldenberg I; McNitt S; Aktas MK; Tabaja C; Ojo A
    J Cardiovasc Electrophysiol; 2024 Jun; 35(6):1203-1211. PubMed ID: 38606650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.